Delapril

Chemical compound


title: "Delapril" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["2-aminoindanes", "ace-inhibitors", "acetic-acids", "enantiopure-drugs", "ethyl-esters", "prodrugs", "propionamides", "drugs-developed-by-takeda-pharmaceutical-company"] description: "Chemical compound" topic_path: "general/2-aminoindanes" source: "https://en.wikipedia.org/wiki/Delapril" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0

::summary Chemical compound ::

| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 444593478 | IUPAC_name = 2-[2,3-dihydro-1H-inden-2-yl-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]amino]acetic acid | image = Delapril.svg | image_class = skin-invert-image | width = 222

| tradename = | Drugs.com = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number_Ref = | CAS_number = 83435-66-9 | ATC_prefix = C09 | ATC_suffix = AA12 | ATC_supplemental = | PubChem = 5362116 | DrugBank_Ref = | DrugBank = | UNII_Ref = | UNII = W77UAL9THI | ChEMBL_Ref = | ChEMBL = 2106126 | KEGG_Ref = | KEGG = D07781 | ChemSpiderID_Ref = | ChemSpiderID = 4514931 | SMILES = O=C(OCC)C@@HCCc3ccccc3 | StdInChI_Ref = | StdInChI = 1S/C26H32N2O5/c1-3-33-26(32)23(14-13-19-9-5-4-6-10-19)27-18(2)25(31)28(17-24(29)30)22-15-20-11-7-8-12-21(20)16-22/h4-12,18,22-23,27H,3,13-17H2,1-2H3,(H,29,30)/t18-,23-/m0/s1 | StdInChIKey_Ref = | StdInChIKey = WOUOLAUOZXOLJQ-MBSDFSHPSA-N

| C=26 | H=32 | N=2 | O=5

Delapril (INN, also known as alindapril) is an ACE inhibitor used as an antihypertensive drug in some European and Asian countries but not in America. It is taken orally, available in 15 mg and 30 mg tablets.

Mechanism

Delapril is a prodrug; it is converted into two active metabolites, 5-hydroxy delapril diacid and delapril diacid. These metabolites bind completely to and inhibit angiotensin-converting enzyme (ACE), hence blocking angiotensin I to angiotensin II conversion. The resulting vasodilation prevents the vasoconstrictive effects of angiotensin II. Angiotensin II-induced aldosterone secretion by the adrenal cortex is also decreased by Delapril, leading to increases in excretion of sodium and therefore increases water outflow.

References

References

  1. (2007). "Manidipine-delapril combination in the management of hypertension". Vascular Health and Risk Management.
  2. "Delapril". Drugs.com.
  3. "Delapril".
  4. "Delapril". U.S. National Library of Medicine.

::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::

2-aminoindanesace-inhibitorsacetic-acidsenantiopure-drugsethyl-estersprodrugspropionamidesdrugs-developed-by-takeda-pharmaceutical-company